Israel's InMode Q4 revenue up 6% but slightly misses estimates

Reuters
Feb 10
Israel's InMode Q4 revenue up 6% but slightly misses estimates

Overview

  • Israel medical tech firm's Q4 revenue slightly missed analyst expectations, EPS met estimates

  • Company's Q4 revenue grew 6% yr/yr to $103.9 mln

  • Returned $127.4 mln to shareholders through share repurchases in 2025

Outlook

  • InMode expects 2026 revenue between $365 mln and $375 mln

  • Company anticipates non-GAAP EPS between $1.43 and $1.48 for 2026

  • InMode plans to launch two new laser-based platforms in 2026

Result Drivers

  • EUROPEAN GROWTH - Record revenue in European operations contributed to Q4 growth, per CFO Yair Malca

  • NORTH AMERICA STABILIZATION - Co sees early signs of stabilization in North America despite ongoing challenges, per CEO Moshe Mizrahy

  • LEADERSHIP CHANGES - Refreshed sales and post-sales leadership teams in North America aim to enhance service capabilities, per President Michael Dennison

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Slight Miss*

$103.85 mln

$104.40 mln (8 Analysts)

Q4 EPS

Meet

$0.42

$0.42 (7 Analysts)

Q4 Net Income

Slight Miss*

$27.03 mln

$27.20 mln (5 Analysts)

Q4 Gross Margin

78.00%

Q4 Pretax Profit

Beat

$31.29 mln

$29.98 mln (6 Analysts)

Q4 Operating Expenses

$55.31 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

  • Wall Street's median 12-month price target for Inmode Ltd is $16.00, about 5.8% above its February 9 closing price of $15.12

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 9 three months ago

Press Release: ID:nPn8kfg7Ja

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10